• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Kala Pharmaceuticals Inc. - Articles and news items

ReNeuron

Kala Pharmaceuticals announces positive results from Phase 3 trial of KPI-121 in cataract surgery

Industry news / 1 April 2015 / Victoria White

Kala has announced positive results from a Phase 3 clinical trial of KPI-121 for the treatment of patients who have undergone cataract surgery…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +